
Overview
A. Kim Ritchey, MD, is a pediatric hematologist/oncologist and is certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics. He is vice-chair of International Affairs of the Department of Pediatrics at UPMC Children’s Hospital of Pittsburgh and is professor of pediatrics at the University of Pittsburgh School of Medicine. He received his medical degree from the University of Cincinnati School of Medicine and completed his pediatric residency at Johns Hopkins Hospital, followed by his fellowship in pediatric hematology/oncology at Yale University. Dr. Ritchey’s clinical interests include all aspects of pediatric hematology and oncology. His career focus is pediatric leukemia and coagulation disorders. He has numerous publications in peer-reviewed journals as well as book chapters and has presented both locally and nationally. He is a member of the American Society of Pediatric Hematology/Oncology where he served as president, as well as the American Society of Hematology, and the American Society of Clinical Oncology.
Dr. Ritchey is rated as an Advanced provider by MediFind in the treatment of Hemophilia A. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Hemophilia B, Hemophilia A, and Leukemia.
His clinical research consists of co-authoring 24 peer reviewed articles and participating in 19 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article and participated in 1 clinical trial in the study of Hemophilia A.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
Locations
4401 Penn Avenue, Floor 3, Pittsburgh, PA 15224
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
19 Clinical Trials
Pediatric Hematology Oncology In Lawrenceville
Frederico Xavier, MD, MS, is the associate clinical director for the Hemophilia Center of Western Pennsylvania and an associate professor of Pediatrics at the University of Pittsburgh School of Medicine. He is board-certified in Pediatrics and in Pediatric Hematology/Oncology. Dr. Xavier completed his medical degree, pediatric residency, and fellowship training in Brazil. He then completed a pediatric residency in New York, pediatric hematology and oncology fellowship at St. Jude Children’s Hospital, and then a pediatric hemostasis fellowship at the Hospital for Sick Children in Toronto, Ontario, Canada. Dr. Xavier completed a master’s degree in clinical research at the Indiana University-Purdue University Indianapolis. He has published peer-reviewed articles and book chapters in the field of pediatric hemostasis and is currently awarded with a research grant to study inflammation in Hemophilia. Dr. Xavier also sits in the Newborn Screening and Follow-up Technical Advisory Board for the Pennsylvania Department of Health. Dr. Xavier also practices at the Hemophilia Center of Western Pennsylvania, a state and federally-funded 501(c)3 charitable organization that provides comprehensive medical care to the residents of Western Pennsylvania with hemophilia and other bleeding and clotting disorders. The functions of the center include diagnosis and evaluation of individuals with bleeding disorders; treatment of bleeding episodes and complications; education of the patient and family, the community, and other medical providers; communication and advocacy; supervision of home care; and research and data collection. View the full list of Dr. Xavier’s publications on PubMed. Dr. Xavier is rated as a Distinguished provider by MediFind in the treatment of Hemophilia A. His top areas of expertise are Hemophilia A, Hemophilic Arthropathy, Hemophilia B, and Von Willebrand Disease (VWD).
Pediatric Hematology Oncology In Lawrenceville
James Cooper, MD, MSc, is clinical director of the Coagulation Program at UPMC Children's Hospital of Pittsburgh. He is also an assistant professor of pediatrics at the University of Pittsburgh School of Medicine. He is board certified in pediatric hematology-oncology and pediatrics. Dr. Cooper earned his medical degree from University of Connecticut School of Medicine. He completed a residency and internship in pediatrics at the University of Connecticut-Connecticut Children's Medical Center followed by a fellowship in pediatric hematology-oncology at UPMC Children's Hospital. Dr. Cooper also earned his master's of science in clinical research at the University of Pittsburgh Institute for Clinical Research Education. In his role as clinical director of the Coagulation Program, Dr. Cooper cares for children with bleeding disorders and thrombosis concerns. As part of that mission, Dr. Cooper and Dr. Tahniat Syed of Adolescent Medicine co-lead a dedicated clinic for young women with menstrual disorders, known as the CHAMP (Comprehensive Hematologic Assessment of Adolescents with Menstrual Problems) Clinic. In addition to coagulation disorders, Dr. Cooper also cares for children with a variety of oncologic and other hematologic problems. Dr. Cooper’s research interests include thrombosis rates in adolescents and young adults versus younger children with cancer and the cost effectiveness of laboratory analysis of clotting disorders in children. He is a member of the American Society of Pediatric Hematology and Oncology, the American Society of Hematology, the Children’s Oncology Group, the Critical Mass Young Adult Alliance, the American Thrombosis & Hemostasis Network, the American Academy of Pediatrics, the Foundation for Women and Girls with Bleeding Disorders, and the Hemostasis and Thrombosis Research Society. View the full list of Dr. Cooper’s publications on PubMed. Dr. Cooper is rated as an Advanced provider by MediFind in the treatment of Hemophilia A. His top areas of expertise are Mesenteric Venous Thrombosis, Venous Thromboembolism (VTE), Hemophilia A, and Blood Clots.
University Of Pittsburgh Physicians
Steven Fein is a Pediatric Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Fein is rated as an Advanced provider by MediFind in the treatment of Hemophilia A. His top areas of expertise are Alpha Thalassemia, Blood Clots, Anemia, Bone Marrow Aspiration, and Splenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Dr. Ritchey isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Hemophilia ADr. Ritchey isAdvanced. Learn about Hemophilia A.
- Hemophilia BDr. Ritchey isAdvanced. Learn about Hemophilia B.
- LeukemiaDr. Ritchey isAdvanced. Learn about Leukemia.
- Experienced
- Chromosome 7p DeletionDr. Ritchey isExperienced. Learn about Chromosome 7p Deletion.
- Hemophilic ArthropathyDr. Ritchey isExperienced. Learn about Hemophilic Arthropathy.
- Infantile NeutropeniaDr. Ritchey isExperienced. Learn about Infantile Neutropenia.
- Juvenile Myelomonocytic Leukemia (JMML)Dr. Ritchey isExperienced. Learn about Juvenile Myelomonocytic Leukemia (JMML).
- Mast Cell Activation Syndrome (MCAS)Dr. Ritchey isExperienced. Learn about Mast Cell Activation Syndrome (MCAS).
- RASopathiesDr. Ritchey isExperienced. Learn about RASopathies.


